Cargando…

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder worldwide. It comprises a spectrum of conditions that range from steatosis to non-alcoholic steatohepatitis, with progression to cirrhosis and hepatocellular carcinoma. Currently, there is no FDA-approved pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jin, Tripathi, Madhulika, Sinha, Rohit A., Singh, Brijesh Kumar, Yen, Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116620/ https://www.ncbi.nlm.nih.gov/pubmed/33490737 http://dx.doi.org/10.20517/2394-5079.2020.134

Ejemplares similares

Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Ji, Yun, et al.
Publicado: (2019)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
por: Wang, Tianjiao, et al.
Publicado: (2021)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2014)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression
por: Zhou, Jin, et al.
Publicado: (2022)

Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients
por: Tsai, Hui-Ju, et al.
Publicado: (2021)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
por: Alisi, Anna, et al.
Publicado: (2012)

The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2019)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Protocol to Generate Senescent Cells from the Mouse Hepatic Cell Line AML12 to Study Hepatic Aging
por: Tripathi, Madhulika, et al.
Publicado: (2020)

Estrogen-Related Receptor Alpha: An Under-Appreciated Potential Target for the Treatment of Metabolic Diseases
por: Tripathi, Madhulika, et al.
Publicado: (2020)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
por: Xie, Chencheng, et al.
Publicado: (2019)

Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents
por: Tokuhara, Daisuke
Publicado: (2021)

Microbial metabolites in non-alcoholic fatty liver disease
por: Zhou, Da, et al.
Publicado: (2019)

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches
por: Borrelli, Antonella, et al.
Publicado: (2018)

Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
por: Quesada-Vázquez, Sergio, et al.
Publicado: (2020)

Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in mice
por: Wang, Qihan, et al.
Publicado: (2021)

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
por: Behary, Jason, et al.
Publicado: (2021)

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
por: Zhang, Xiang, et al.
Publicado: (2021)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

Hyperhomocysteinemia causes ER stress and impaired autophagy that is reversed by Vitamin B supplementation
por: Tripathi, Madhulika, et al.
Publicado: (2016)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
por: Bruinstroop, Eveline, et al.
Publicado: (2021)

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Raza, Sana, et al.
Publicado: (2019)

Corrigendum: The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota
por: Liu, Huilin, et al.
Publicado: (2018)

Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota
por: Luo, Hanyan, et al.
Publicado: (2021)

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
por: Zhang, Xiao-Lei, et al.
Publicado: (2023)

Interaction between mucus layer and gut microbiota in non-alcoholic fatty liver disease: Soil and seeds
por: Zhang, Binbin, et al.
Publicado: (2023)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
por: Li, Zhonglin, et al.
Publicado: (2023)

Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Pan, Xiongfeng, et al.
Publicado: (2020)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota
por: Ahmed, Basma A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sjpm212ajufkpgbddais9mvg2c